[Physiopathological principles in the treatment of orthostatic hypotension using mineralocorticoids].
D000804:Angiotensin II / Q000502:physiology; D002302:Cardiac Output; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D006339:Heart Rate; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008901:Mineralocorticoids / Q000494:pharmacology / Q000627:therapeutic use*; D011187:Posture; D012083:Renin / Q000502:physiology; D014680:Veins / Q000503:physiopathology; D014690:Venous Pressure
D008901:Mineralocorticoids; D000804:Angiotensin II; D004877:Ergoloid Mesylates; D012083:Renin
Pathophysiologische Grundlagen der Mineralocorticoid-Behandlung bei orthostatischer Kreislaufregulationsstörung.